MBLA to Differentiate IRIS From Treatment Failure in Extrapulmonary Tuberculosis
MBLA to Differentiate IRIS From Treatment Failure in Extrapulmonary Tuberculosis
Not yet recruiting · NCT07778082 · Registry updated 2026-08-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MBLA to Differentiate IRIS From Treatment Failure in Extrapulmonary Tuberculosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Hemic and Lymphatic Diseases, Infections, Lymphadenopathy, Tuberculosis, Extrapulmonary, bacterial infectious disease, gram-positive bacterial infections, lymphatic system disorder, mycobacterial infectious disease, tuberculosis | Not yet recruiting | Not stated | 2026-08-31 | NCT07778082 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Research Center Borstel | 11 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Research Center Borstel, Leibniz Lung Center | Borstel | Germany | 1 |